A review last year by NHS medical director, Professor Sir Bruce Keogh, concluded the PIP breast implants were not toxic or carcinogenic.
Today's European study said the implants have not been associated with higher risks of cancer.
It added: "Laboratory tests on PIP implants have been negative for cytotoxicity and genotoxicity."
The study said PIP implants have been subjected to chemical analysis "in an effort to find organic and inorganic compounds (including heavy metals) that may be potentially toxic, but none have been found even at very low levels".
European regulators have concluded that there is no evidence that women who have PIP breast implants are at higher risk of cancer.
Women also do not need to have the faulty implants removed as a precaution although they may wish to have them taken out if they feel anxious, according to a review of PIP safety published by the European Commission's Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR).
Around 47,000 British women are thought to have been given the implants manufactured by the closed French company Poly Implant Prothese (PIP).
Women who have breast implants and go on to have breast cancer have a greater risk of dying from the disease than those without, a new study suggests.
Researchers said that patients with cosmetic implants have a 38% higher risk of dying from breast cancer than women who do not have implants.
The small study, published on bmj.com, also found that women with implants could be diagnosed with breast cancer at a later stage than those without.
Previous research has suggested that implants can make it more difficult to detect cancer at an early stage because they can create shadows on mammograms that obscure breast tissue.
Jan Spivey was given PIP breast implants after having cancer, outside the court in Marseilles, where she is giving evidence in the trial of Jean-Claude Mas, Jan said she was, "heartbroken to see man who has created so much suffering to to many women."
The head of the French company that is accused of selling 300,000 faulty breast implants has gone on trial.
Here is a look back at the breast implant scandal:
- Poly Implant Prothèse (PIP) was founded by Jean-Claude Mas in 1991.
- Before the company went into liquidation in 2011, it is thought around 300,000 women were sold faulty breast implants.
- Concerns were first raised in France over PIP's high rupture rate in 2009.
- In 2010, France suspended the marketing, distribution, export and use of PIP implants.
- The French government said it recommended all women with the implants to have them removed in late 2011.
- A review ordered by the Health Secretary found that PIP implants were more likely to rupture or leak.
- Mas offered an apology on April 24, 2013, for the implants, saying: "I apologise to the plantiffs for the gel used by PIP since 1992."
- The Frenchman and four PIP executives face aggravated fraud charges and face five years each in prison.
Sir Bruce Keogh said the review into cosmetic surgery should be complete by the end of the year. Keogh told BBC Breakfast the review will address the "cacophony of concern" about "grubby practice" that was inflicting some parts of the industry.
This whole debate has raised a cacophony of concern across society. There are people who are concerned about the regulation, there are people who are very concerned about the qualifications of those who are conducting, in the dark recesses of the cosmetic industry, procedures that they are not qualified to do.
There are, sadly though, some parts where there are some pretty grubby practices going on and that's why we're having the review.
A major review into cosmetic surgery is being launched in light of the PIP scandal. Daybreak speaks to inquiry author Sir Bruce Keogh.
A major review into cosmetic surgery is being launched in light of the PIP scandal. Daybreak's Tiffany Royce reports.